(December 20, 2023, 1:01 PM EST) -- WASHINGTON, D.C. — If a federal judge’s ruling finding rules governing how insurers handle drug manufacturers’ assistance programs under the Patient Protection and Affordable Care Act (ACA) mandated certain actions by the government it would create an extraordinary situation, and to the extent that it did the court should clarify the specific enforcement actions the ruling envisions, the government says in a reply brief in support of a motion to clarify....